Towards the eradication of HPV infection through universal specific vaccination
Open Access
- 11 July 2013
- journal article
- review article
- Published by Springer Nature in BMC Public Health
- Vol. 13 (1) , 642-11
- https://doi.org/10.1186/1471-2458-13-642
Abstract
Background: The Human Papillomavirus (HPV) is generally recognized to be the direct cause of cervical cancer. The development of effective anti-HPV vaccines, included in the portfolio of recommended vaccinations for any given community, led to the consolidation in many countries of immunization programs to prevent HPV-related cervical cancers. In recent years, increasing evidence in epidemiology and molecular biology have supported the oncogenic role of HPV in the development of other neoplasm including condylomas and penile, anal, vulvar, vaginal, and oro-pharyngeal cancers. Men play a key role in the paradigm of HPV infection: both as patients and as part of the mechanisms of transmission. Data show they are affected almost as often as women. Moreover, no screening procedures for HPV-related disease prevention are applied in men, who fail to undergo routine medical testing by any medical specialist at all. They also do not benefit from government prevention strategies.Discussion: A panel of experts convened to focus on scientific, medical, and economic studies, and on the achievements from health organizations’ intervention programs on the matter. One of the goals was to discuss on the critical issues emerging from the ongoing global implementation of HPV vaccination. A second goal was to identify contributions which could overcome the barriers that impede or delay effective vaccination programs whose purpose is to eradicate the HPV infection both in women and men.Summary: The reviewed studies on the natural history of HPV infection and related diseases in women and men, the increasing experience of HPV vaccination in women, the analysis of clinical effectiveness vs economic efficacy of HPV vaccination, are even more supportive of the economic sustainability of vaccination programs both in women and men. Those achievements address increasing and needed attention to the issue of social equity in healthcare for both genders.Keywords
This publication has 105 references indexed in Scilit:
- Evidence of immune memory 8.5 years following administration of a prophylactic human papillomavirus type 16 vaccineJournal of Clinical Virology, 2011
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial NeoplasiaNew England Journal of Medicine, 2011
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological studyThe Lancet, 2011
- Human Papillomavirus in Infants: Transmission, Prevalence, and PersistenceJournal of Pediatric and Adolescent Gynecology, 2011
- Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyThe Lancet, 2011
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesNew England Journal of Medicine, 2011
- Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, UgandaThe Lancet, 2011
- Impact of vaccinating boys and men against HPV in the United StatesVaccine, 2010
- Human Papillomavirus-Related Disease in Men: Not Just a Women's IssuePublished by Elsevier ,2010
- The search for infectious causes of human cancers: Where and whyVirology, 2009